Back to search

Article

<i>In Vivo</i> Efficacy of ABHD17 Inhibition Validates the Palmitoylation Cycle as a Therapeutic Target in <i>NRAS</i> -Mutant Cancer

2025-03-21

Abstract excerpt

<h4>SUMMARY</h4> Ras proteins are functionally dependent on one or more lipid modifications. 1,2 The dynamic palmitoylation of N-Ras by DHHC palmitoyl acyltransferases and depalmitoylation by ABHD17 serine hydrolases is essential for the growth of NRAS -mutant acute myeloid leukemia (AML) cells. 3–6 Here we show that ABD778, an in vivo -active ABHD17 inhibitor, selectively reduces the growth of NRAS -mutant...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
07c867d4-fc59-5c6a-8cf6-14129f15501a
DOI
10.1101/2025.03.20.644389
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>In Vivo</i> Efficacy of ABHD17 Inhibition Validates the Palmitoylation Cycle as a Therapeutic Target in <i>NRAS</i> -Mutant CancerDOI 10.1101/2025.03.20.644389
Select a neighboring publication to make it the new centre.